These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8623801)

  • 1. Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration.
    Casson PR; Straughn AB; Umstot ES; Abraham GE; Carson SA; Buster JE
    Am J Obstet Gynecol; 1996 Feb; 174(2):649-53. PubMed ID: 8623801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies.
    Buster JE; Casson PR; Straughn AB; Dale D; Umstot ES; Chiamori N; Abraham GE
    Am J Obstet Gynecol; 1992 Apr; 166(4):1163-8; discussion 1168-70. PubMed ID: 1533090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers.
    Davidson M; Marwah A; Sawchuk RJ; Maki K; Marwah P; Weeks C; Lardy H
    Clin Invest Med; 2000 Oct; 23(5):300-10. PubMed ID: 11055323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.
    Casson PR; Faquin LC; Stentz FB; Straughn AB; Andersen RN; Abraham GE; Buster JE
    Fertil Steril; 1995 May; 63(5):1027-31. PubMed ID: 7720912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.
    Poretsky L; Song L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison C; Haller I; Rabkin J
    Horm Metab Res; 2009 Mar; 41(3):244-9. PubMed ID: 18810712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.
    Barnhart KT; Freeman E; Grisso JA; Rader DJ; Sammel M; Kapoor S; Nestler JE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3896-902. PubMed ID: 10566625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S; Massien C; Lahlou N; Roger M; Debuire B; Diquet B; Chatellier G; Azizi M; Faucounau V; Porchet H; Forette F; Baulieu EE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
    Barton DL; Shuster LT; Dockter T; Atherton PJ; Thielen J; Birrell SN; Sood R; Griffin P; Terstriep SA; Mattar B; Lafky JM; Loprinzi CL
    Support Care Cancer; 2018 Apr; 26(4):1335-1343. PubMed ID: 29164377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C; Labrie F; Archer DF; Ke Y; Gonthier R; Simard JN; Lavoie L; Vaillancourt M; Montesino M; Balser J; Moyneur É;
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
    Suh-Burgmann E; Sivret J; Duska LR; Del Carmen M; Seiden MV
    Gynecol Obstet Invest; 2003; 55(1):25-31. PubMed ID: 12624548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
    Keane KN; Hinchliffe PM; Namdar N; Conceicao JL; Newsholme P; Yovich JL
    Drug Des Devel Ther; 2015; 9():5569-78. PubMed ID: 26487801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute oral administration of dehydroepiandrosterone in male subjects: effect of age on bioavailability, sulfoconjugation and bioconversion in other steroids.
    Valenti G; Banchini A; Denti L; Maggio M; Ceresini G; Ceda GP
    J Endocrinol Invest; 1999; 22(10 Suppl):24-8. PubMed ID: 10727030
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intravaginal dehydroepiandrosterone on vaginal histomorphology, sex steroid receptor expression and cell proliferation in the rat.
    Berger L; El-Alfy M; Labrie F
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):67-80. PubMed ID: 18242978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The determination of testosterone and dehydroepiandrosterone after dehydroepiandrosterone sulfate application in late pregnancy].
    Seiler E; Schollberg K
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():28-31. PubMed ID: 6211050
    [No Abstract]   [Full Text] [Related]  

  • 17. The free testosterone to dehydroepiandrosterone sulphate molar ratio as a marker of visceral fat accumulation in premenopausal obese women.
    De Pergola G; Triggiani V; Giorgino F; Cospite MR; Garruti G; Cignarelli M; Guastamacchia E; Giorgino R
    Int J Obes Relat Metab Disord; 1994 Oct; 18(10):659-64. PubMed ID: 7866460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):178-94. PubMed ID: 18598765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
    Stanczyk FZ; Slater CC; Ramos DE; Azen C; Cherala G; Hakala C; Abraham G; Roy S
    Menopause; 2009; 16(2):272-8. PubMed ID: 19098687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    Zimmerman Y; Coelingh Bennink HJ; Wouters W; Ebes F; Fauser BC
    Eur J Contracept Reprod Health Care; 2013 Dec; 18(6):489-500. PubMed ID: 23944295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.